Geron Corporation GERN
1.26
0.00
0.00%
as of 25 Sep
- Market cap
- $815.9M
- P/E
- 0.0×
Follow GERN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.98 | 4.79 | 5.09 | 4.20 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(67.32) | (39.88) | (15.85) | (54.24) | |
P/B ratio |
3.67 | 3.90 | 4.35 | 3.93 | |
Price to Tangible BV |
3.67 | 3.90 | 4.35 | 3.93 | |
EV/Sales |
3.94 | 3.87 | 4.46 | 3.65 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.43) | (6.41) | (6.94) | (6.53) | |
EV/FCF |
(5.44) | (6.40) | (6.92) | (6.51) | |
Quick Ratio |
4.79 | 3.58 | 4.87 | 5.07 | |
Current Ratio |
5.96 | 4.66 | 6.78 | 6.92 | |
Net Debt/EBITDA |
17.74 | 9.09 | 650.34 | 14.52 | |
Debt/Assets |
21.02% | 20.95% | 22.44% | 23.15% | |
Debt/Equity |
0.48 | 0.53 | 0.52 | 0.55 | |
Asset Turnover |
0.36 | 0.32 | 0.36 | 0.38 | |
Operating CF/Net income |
0.74 | 0.76 | 17.27 | 0.95 | |
Capex/Depreciation |
(0.09) | 0.00 | 0.55 | 2.86 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
44.61% | 28.22% | 28.85% | 38.33% | |
Selling, General and Administrative Expense of Revenue |
82.58% | 86.78% | 68.34% | 67.61% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
14.34% | 12.06% | 9.48% | 8.61% | |
Graham Net Nets |
0.22 | 0.20 | 0.19 | 0.22 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.76%) | (9.85%) | (7.07%) | (8.23%) | |
Free Cash Flow Yield |
(14.53%) | (12.62%) | (12.66%) | (13.37%) | |
Revenue per Share |
0.07 | 0.07 | 0.08 | 0.09 | |
Operating CF per Share |
(0.02) | (0.03) | (0.09) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.03) | (0.09) | (0.02) | |
Cash per Share |
0.57 | 0.54 | 0.47 | 0.45 | |
Shareholders Equity per Share |
0.37 | 0.34 | 0.34 | 0.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.37 | 0.34 | 0.34 | 0.33 | |
Free Cash Flow |
(13.49) | (22.07) | (63.16) | (16.05) | |
Working Capital |
434.63 | 408.73 | 424.96 | 416.01 | |
Capital Expenditures |
0.09 | 0.00 | (0.25) | (0.22) | |
Net Current Asset Value |
203.67 | 175.60 | 193.52 | 185.94 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(39.02%) | (60.11%) | (7.03%) | (29.02%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
33.87 | 39.01 | 39.04 | 46.43 | |
Average Payables |
12.42 | 9.93 | 10.38 | 8.52 | |
Average Inventory |
57.85 | 77.68 | 94.75 | 96.36 | |
Average Assets |
506.17 | 582.16 | 548.29 | 537.10 | |
Average Common Equity |
270.50 | 253.10 | 248.67 | 239.07 |
Columns are period end dates